SVAS BIOSANA SPA (SVS.MI) Fundamental Analysis & Valuation

BIT:SVS • IT0005469264

Current stock price

8.84 EUR
+0.32 (+3.76%)
Last:

This SVS.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. SVS.MI Profitability Analysis

1.1 Basic Checks

  • SVS had positive earnings in the past year.
  • In the past year SVS has reported a negative cash flow from operations.
  • Each year in the past 5 years SVS has been profitable.
  • Each year in the past 5 years SVS had a positive operating cash flow.
SVS.MI Yearly Net Income VS EBIT VS OCF VS FCFSVS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M 10M

1.2 Ratios

  • SVS has a Return On Assets of 3.75%. This is comparable to the rest of the industry: SVS outperforms 53.85% of its industry peers.
  • The Return On Equity of SVS (10.43%) is better than 69.23% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 8.04%, SVS is in the better half of the industry, outperforming 66.15% of the companies in the same industry.
  • SVS had an Average Return On Invested Capital over the past 3 years of 6.63%. This is below the industry average of 10.21%.
  • The 3 year average ROIC (6.63%) for SVS is below the current ROIC(8.04%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.75%
ROE 10.43%
ROIC 8.04%
ROA(3y)3.03%
ROA(5y)2.75%
ROE(3y)8.2%
ROE(5y)7.97%
ROIC(3y)6.63%
ROIC(5y)6.34%
SVS.MI Yearly ROA, ROE, ROICSVS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • SVS's Profit Margin of 5.09% is in line compared to the rest of the industry. SVS outperforms 49.23% of its industry peers.
  • In the last couple of years the Profit Margin of SVS has grown nicely.
  • The Operating Margin of SVS (8.71%) is comparable to the rest of the industry.
  • SVS's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 26.17%, SVS is not doing good in the industry: 87.69% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of SVS has declined.
Industry RankSector Rank
OM 8.71%
PM (TTM) 5.09%
GM 26.17%
OM growth 3Y3.27%
OM growth 5Y3.94%
PM growth 3Y7.81%
PM growth 5Y7.66%
GM growth 3Y-3.21%
GM growth 5Y-2.88%
SVS.MI Yearly Profit, Operating, Gross MarginsSVS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. SVS.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SVS is creating some value.
  • Compared to 1 year ago, SVS has less shares outstanding
  • The number of shares outstanding for SVS has been reduced compared to 5 years ago.
  • SVS has a better debt/assets ratio than last year.
SVS.MI Yearly Shares OutstandingSVS.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
SVS.MI Yearly Total Debt VS Total AssetsSVS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • SVS has an Altman-Z score of 1.82. This is not the best score and indicates that SVS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • SVS has a worse Altman-Z score (1.82) than 67.69% of its industry peers.
  • A Debt/Equity ratio of 0.62 indicates that SVS is somewhat dependend on debt financing.
  • SVS's Debt to Equity ratio of 0.62 is on the low side compared to the rest of the industry. SVS is outperformed by 67.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Altman-Z 1.82
ROIC/WACC1.14
WACC7.08%
SVS.MI Yearly LT Debt VS Equity VS FCFSVS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • SVS has a Current Ratio of 1.82. This is a normal value and indicates that SVS is financially healthy and should not expect problems in meeting its short term obligations.
  • SVS has a Current ratio (1.82) which is comparable to the rest of the industry.
  • SVS has a Quick Ratio of 1.34. This is a normal value and indicates that SVS is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of SVS (1.34) is better than 63.08% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.34
SVS.MI Yearly Current Assets VS Current LiabilitesSVS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. SVS.MI Growth Analysis

3.1 Past

  • SVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.41%, which is quite impressive.
  • Measured over the past years, SVS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 19.97% on average per year.
  • Looking at the last year, SVS shows a quite strong growth in Revenue. The Revenue has grown by 9.07% in the last year.
  • The Revenue has been growing by 10.34% on average over the past years. This is quite good.
EPS 1Y (TTM)24.41%
EPS 3Y23.97%
EPS 5Y19.97%
EPS Q2Q%34.09%
Revenue 1Y (TTM)9.07%
Revenue growth 3Y14.06%
Revenue growth 5Y10.34%
Sales Q2Q%21.03%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.83% on average over the next years. This is quite good.
  • Based on estimates for the next years, SVS will show a quite strong growth in Revenue. The Revenue will grow by 9.07% on average per year.
EPS Next Y33.33%
EPS Next 2Y17.92%
EPS Next 3Y14.83%
EPS Next 5YN/A
Revenue Next Year19.23%
Revenue Next 2Y11.86%
Revenue Next 3Y9.07%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SVS.MI Yearly Revenue VS EstimatesSVS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
SVS.MI Yearly EPS VS EstimatesSVS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

7

4. SVS.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 6.96, which indicates a rather cheap valuation of SVS.
  • 100.00% of the companies in the same industry are more expensive than SVS, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of SVS to the average of the S&P500 Index (26.78), we can say SVS is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 5.99, the valuation of SVS can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, SVS is valued cheaper than 95.38% of the companies in the same industry.
  • SVS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.54.
Industry RankSector Rank
PE 6.96
Fwd PE 5.99
SVS.MI Price Earnings VS Forward Price EarningsSVS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SVS indicates a rather cheap valuation: SVS is cheaper than 93.85% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.76
SVS.MI Per share dataSVS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as SVS's earnings are expected to grow with 14.83% in the coming years.
PEG (NY)0.21
PEG (5Y)0.35
EPS Next 2Y17.92%
EPS Next 3Y14.83%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. SVS.MI Dividend Analysis

5.1 Amount

  • SVS has a Yearly Dividend Yield of 2.78%.
  • Compared to an average industry Dividend Yield of 1.20, SVS pays a better dividend. On top of this SVS pays more dividend than 87.69% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, SVS pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.78%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • SVS pays out 19.64% of its income as dividend. This is a sustainable payout ratio.
DP19.64%
EPS Next 2Y17.92%
EPS Next 3Y14.83%
SVS.MI Yearly Income VS Free CF VS DividendSVS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M
SVS.MI Dividend Payout.SVS.MI Dividend Payout, showing the Payout Ratio.SVS.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SVS.MI Fundamentals: All Metrics, Ratios and Statistics

SVAS BIOSANA SPA

BIT:SVS (2/16/2026, 7:00:00 PM)

8.84

+0.32 (+3.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners5.58%
Inst Owner ChangeN/A
Ins Owners64.79%
Ins Owner ChangeN/A
Market Cap49.50M
Revenue(TTM)132.55M
Net Income(TTM)6.74M
Analysts80
Price Target17.44 (97.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.78%
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DP19.64%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)15.93%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 6.96
Fwd PE 5.99
P/S 0.37
P/FCF N/A
P/OCF N/A
P/B 0.77
P/tB 1.06
EV/EBITDA 4.76
EPS(TTM)1.27
EY14.37%
EPS(NY)1.47
Fwd EY16.68%
FCF(TTM)-1.21
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS23.67
BVpS11.54
TBVpS8.36
PEG (NY)0.21
PEG (5Y)0.35
Graham Number18.16
Profitability
Industry RankSector Rank
ROA 3.75%
ROE 10.43%
ROCE 10.81%
ROIC 8.04%
ROICexc 10.91%
ROICexgc 14.1%
OM 8.71%
PM (TTM) 5.09%
GM 26.17%
FCFM N/A
ROA(3y)3.03%
ROA(5y)2.75%
ROE(3y)8.2%
ROE(5y)7.97%
ROIC(3y)6.63%
ROIC(5y)6.34%
ROICexc(3y)10.45%
ROICexc(5y)9.43%
ROICexgc(3y)12.81%
ROICexgc(5y)11.57%
ROCE(3y)8.91%
ROCE(5y)8.53%
ROICexgc growth 3Y10.44%
ROICexgc growth 5Y8.61%
ROICexc growth 3Y11.05%
ROICexc growth 5Y7.72%
OM growth 3Y3.27%
OM growth 5Y3.94%
PM growth 3Y7.81%
PM growth 5Y7.66%
GM growth 3Y-3.21%
GM growth 5Y-2.88%
F-Score5
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Debt/EBITDA 2.36
Cap/Depr 113.41%
Cap/Sales 4.68%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.34
Altman-Z 1.82
F-Score5
WACC7.08%
ROIC/WACC1.14
Cap/Depr(3y)111.56%
Cap/Depr(5y)102.51%
Cap/Sales(3y)5.01%
Cap/Sales(5y)4.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.41%
EPS 3Y23.97%
EPS 5Y19.97%
EPS Q2Q%34.09%
EPS Next Y33.33%
EPS Next 2Y17.92%
EPS Next 3Y14.83%
EPS Next 5YN/A
Revenue 1Y (TTM)9.07%
Revenue growth 3Y14.06%
Revenue growth 5Y10.34%
Sales Q2Q%21.03%
Revenue Next Year19.23%
Revenue Next 2Y11.86%
Revenue Next 3Y9.07%
Revenue Next 5YN/A
EBIT growth 1Y17.64%
EBIT growth 3Y17.79%
EBIT growth 5Y14.69%
EBIT Next Year94.24%
EBIT Next 3Y29.1%
EBIT Next 5YN/A
FCF growth 1Y-245.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-105.92%
OCF growth 3Y26.58%
OCF growth 5Y-3.68%

SVAS BIOSANA SPA / SVS.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SVAS BIOSANA SPA (SVS.MI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to SVS.MI.


Can you provide the valuation status for SVAS BIOSANA SPA?

ChartMill assigns a valuation rating of 7 / 10 to SVAS BIOSANA SPA (SVS.MI). This can be considered as Undervalued.


Can you provide the profitability details for SVAS BIOSANA SPA?

SVAS BIOSANA SPA (SVS.MI) has a profitability rating of 5 / 10.


What are the PE and PB ratios of SVAS BIOSANA SPA (SVS.MI) stock?

The Price/Earnings (PE) ratio for SVAS BIOSANA SPA (SVS.MI) is 6.96 and the Price/Book (PB) ratio is 0.77.


How financially healthy is SVAS BIOSANA SPA?

The financial health rating of SVAS BIOSANA SPA (SVS.MI) is 4 / 10.